A significant portion of this edition focuses on monoclonal
antibodies, vaccines, and gene directed therapies and how they
can greatly improve treatment outcomes. A new chapter on end-of-
life care is also included. Three distinguished new editors?
Richard R. Barakat, MD, Maurie Markman, MD, and Marcus E.
Randall, MD now join the editorial team.